Botulinum toxin for the upper limb after stroke (BoTULS) trial: Effect on impairment, activity limitation, and pain

Stroke

Volumn 42, Issue 5, 2011, Pages 1371-1379

  Shaw, Lisa C ^a   Price, Christopher I M ^b   Van Wijck, Frederike M J ^c   Shackley, Phil ^a   Steen, Nick ^a   Barnes, Michael P ^d   Ford, Gary A ^a,e   Graham, Laura A ^d   Rodgers, Helen ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^c QUEEN MARGARET UNIVERSITY   (United Kingdom)

^d TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^e NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

botulinum toxin; randomized controlled trial; spasticity; stroke; upper limb

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARM; ARM MOVEMENT; ARTICLE; COMMON COLD SYMPTOM; CONTROLLED STUDY; DYSPHAGIA; FEMALE; FLU LIKE SYNDROME; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; MUSCLE TONE; OUTCOME ASSESSMENT; PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPASTICITY; STATISTICAL SIGNIFICANCE; STROKE; TREATMENT DURATION; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTI-DYSKINESIA AGENTS; ARM; BOTULINUM TOXINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE SPASTICITY; MUSCLE STRENGTH; MUSCLE TONUS; PAIN; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 79955482957     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.582197     Document Type: Article

References (16)

1. Watkins CL, Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK. Prevalence ofspasticity post stroke. Clin Rehabil. 2002;16:515-522
2. Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society ofPhysiotherapy, Association ofChartered Physiother-apists Interested in Neurology. Spasticity in Adults: Management Using Botulinum Toxin. National Guidelines. London: Royal College of Phy-sicians; 2009.
3. Dolly JO, Aoki KR. The structure and mode of action of different botulinum toxins. Eur J Neurol 2006;13(suppl 4):1-9. (Pubitemid 44748278)
4. Garces K, McCormick A, McGahan L, Skidmore B. Botulinum Toxin A for Upper and Lower Limb Spasticity: A Systematic Review [Technology report no 51]. Ottawa: Canadian Coordinating Office for Health Tech-nology Assessment; 2005.
5. Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil. 1998;12:381-388. (Pubitemid 28464099)
6. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of bot-ulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial [erratum appears in J Neurol Neurosurg Psychiatry 2001;70:821]. J Neurol Neu-rosurg Psychiatry. 2000;69:217-221. (Pubitemid 30466027)
7. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee C-H, Jenkins S, Turkel C, Botox Post-Stroke Spasticity Study Group. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;347:395-400. (Pubitemid 34851831)
8. Shaw L, Rodgers H. Botulinum toxin type A for upper limb spasticity after stroke. Exp Rev Neurother. 2009;9:1713-1725.
9. Rodgers H, Shaw L, Price C, van Wijck F, Barnes M, Graham L, Ford G, Shackley P, Steen N. Study design and methods ofthe BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effec-tiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Trials. 2008;9:59.
10. Barnes MP, Bhakta BB, Moore P, Richardson D, Salisbury C, Thornton H, Turner-Stokes L, Ward A. The Management of Adults With Spasticity Using Botulinum Toxin: A Guide to Clinical Practice. Surrey: Radius Healthcare; 2001.
11. van der Lee JH, Wagenaar RC, Lankhorst GJ, Vogelaar TW, Deville WL, Bouter LM. Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial. Stroke. 1999;30: 2369-2375. (Pubitemid 29517737)
12. Ada L, O'Dwyer N, O'Neill E. Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: an observational study. Disabil Rehabil. 2006;28:891-897.
13. Leonard CT, Gardipee KA, Koontz JR, Anderson J-H, Wilkins SA. Correlation between impairment and motor performance during reaching tasks in subjects with spastic hemiparesis. J Rehabil Med. 2006;38: 243-249.
14. Sheean GL. Botulinum treatment of spasticity: why is it so difficult to show a functional benefit? Curr Opin Neurol. 2001;14:771-776. (Pubitemid 34060116)
15. Suputtitada A, Suwanwela NC. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity. Disabil Rehabil. 2005; 27:176-184. (Pubitemid 40468158)
16. Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, Rodgers H. A review of the properties and limitations of the Ashworth and Modified Ashworth Scales as measures of spasticity. Clin Rehabil. 1999;13: 373-383. (Pubitemid 29425632)